Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Foster

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
International Journal of Molecular Medicine|April 2, 2011
Expression of membrane and nuclear progesterone receptors in two human placental choriocarcinoma cell lines (JEG-3 and BeWo): Effects of syncytializationElena Zachariades, Helen Foster, Anastasia Goumenou, et al.
Anticancer Research|October 15, 2010
Differential expression of mTOR signalling components in drug resistance in ovarian cancerHelen Foster, Helen M Coley, Anastasia Goumenou, et al.
Molecular and Cellular Neurosciences|March 16, 2020
Hippocampal synaptic and membrane function in the DBA/2J-mdx mouse model of Duchenne muscular dystrophyRiccardo Bianchi, Wouter Eilers, Federica Pellati, et al.
International Journal of Molecular Medicine|December 4, 2009
Expression of mTOR and downstream signalling components in the JEG-3 and BeWo human placental choriocarcinoma cell linesDionisis Mparmpakas, Elena Zachariades, Helen Foster, et al.
Nature Cell Biology|July 26, 2016
The mammalian dynein-dynactin complex is a strong opponent to kinesin in a tug-of-war competitionVladislav Belyy, Max A Schlager, Helen Foster, et al.
Human Gene Therapy|June 27, 2008
Human apolipoprotein E expression from mouse skeletal muscle by electrotransfer of nonviral DNA (plasmid) and pseudotyped recombinant adeno-associated virus (AAV2/7)Vanessa Evans, Helen Foster, Ian R Graham, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 4, 2008
Codon and mRNA sequence optimization of microdystrophin transgenes improves expression and physiological outcome in dystrophic mdx mice following AAV2/8 gene transferHelen Foster, Paul S Sharp, Takis Athanasopoulos, et al.
Human Gene Therapy|April 2, 2011
Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of α1-syntrophin and α-dystrobrevin in skeletal muscles of mdx miceTaeyoung Koo, Alberto Malerba, Takis Athanasopoulos, et al.
Archives of Disease in Childhood|September 16, 2015
Influence of past breast feeding on pattern and severity of presentation of juvenile idiopathic arthritisKimme L Hyrich, Eileen Baildam, Hannah Pickford, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 10, 2025
Measuring alignment between the ADRC UDS data elements, FDA, and EHR data standardsZhan Wang, Kayla Torres, Helen Foster, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Medicine|April 2, 2011
Expression of membrane and nuclear progesterone receptors in two human placental choriocarcinoma cell lines (JEG-3 and BeWo): Effects of syncytializationElena Zachariades, Helen Foster, Anastasia Goumenou, et al.
Anticancer Research|October 15, 2010
Differential expression of mTOR signalling components in drug resistance in ovarian cancerHelen Foster, Helen M Coley, Anastasia Goumenou, et al.
Molecular and Cellular Neurosciences|March 16, 2020
Hippocampal synaptic and membrane function in the DBA/2J-mdx mouse model of Duchenne muscular dystrophyRiccardo Bianchi, Wouter Eilers, Federica Pellati, et al.
International Journal of Molecular Medicine|December 4, 2009
Expression of mTOR and downstream signalling components in the JEG-3 and BeWo human placental choriocarcinoma cell linesDionisis Mparmpakas, Elena Zachariades, Helen Foster, et al.
Nature Cell Biology|July 26, 2016
The mammalian dynein-dynactin complex is a strong opponent to kinesin in a tug-of-war competitionVladislav Belyy, Max A Schlager, Helen Foster, et al.
Human Gene Therapy|June 27, 2008
Human apolipoprotein E expression from mouse skeletal muscle by electrotransfer of nonviral DNA (plasmid) and pseudotyped recombinant adeno-associated virus (AAV2/7)Vanessa Evans, Helen Foster, Ian R Graham, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 4, 2008
Codon and mRNA sequence optimization of microdystrophin transgenes improves expression and physiological outcome in dystrophic mdx mice following AAV2/8 gene transferHelen Foster, Paul S Sharp, Takis Athanasopoulos, et al.
Human Gene Therapy|April 2, 2011
Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of α1-syntrophin and α-dystrobrevin in skeletal muscles of mdx miceTaeyoung Koo, Alberto Malerba, Takis Athanasopoulos, et al.
Archives of Disease in Childhood|September 16, 2015
Influence of past breast feeding on pattern and severity of presentation of juvenile idiopathic arthritisKimme L Hyrich, Eileen Baildam, Hannah Pickford, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 10, 2025
Measuring alignment between the ADRC UDS data elements, FDA, and EHR data standardsZhan Wang, Kayla Torres, Helen Foster, et al.
Pageof 6